“Aromasin Basics
Pharmacia and Upjohn first made Exemestane to treat breast cancer in women who had gone through menopause. It is used as a second-line treatment for breast cancer when other first-line therapies, like Nolvadex, haven’t worked. Shortly after its creation, the Food and Drug Administration (FDA) approved using Aromasin (Exemestane) for retail, among other prescription drugs, in 1999.
The drug didn’t sell under the Aromasin brand name until 2000. Since it was first made available, its use and sales have spread worldwide, and it is now used in almost every country. There is just one legally made and sold Aromasin product at this time, and it is readily available worldwide under the brand name Aromasin. Aromasin (Exemestane) comes in tablets of 25mg, the standard dose. However, research shows that it works at doses as low as 2.5mg daily.”
canadiananabolics.is
Thank you so much for your answer!
The search results contain information about other breast cancer treatments like trastuzumab (approved in 1998) and newer medications, but nothing specific about exemestane. To provide accurate information about exemestane's history, additional search results would be needed.
AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.